Page last updated: 2024-08-22

lutetium and paclitaxel

lutetium has been researched along with paclitaxel in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alvarez, RD; Austin, JM; Grizzle, WE; Khazaeli, MB; Kilgore, LC; Lin, CY; LoBuglio, AF; Macey, DJ; Meredith, RF; Partridge, EE; Schlom, J1
Eberwein, DJ; Ingram, AC; Knick, VC; Murray, DM; Ryan, CH; Stimmel, JB; Thurmond, LM; Witherspoon, SM1

Trials

1 trial(s) available for lutetium and paclitaxel

ArticleYear
Intraperitoneal radioimmunochemotherapy of ovarian cancer: a phase I study.
    Cancer biotherapy & radiopharmaceuticals, 2001, Volume: 16, Issue:4

    Topics: Adenocarcinoma; Adolescent; Adult; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Injections, Intraperitoneal; Interferon Type I; Lutetium; Maximum Tolerated Dose; Middle Aged; Ovarian Neoplasms; Paclitaxel; Radioimmunotherapy; Radioisotopes; Radionuclide Imaging; Recombinant Proteins; Treatment Outcome

2001

Other Studies

1 other study(ies) available for lutetium and paclitaxel

ArticleYear
Adenocarcinoma cells exposed in vitro to Navelbine or Taxol increase Ep-CAM expression through a novel mechanism.
    Cancer immunology, immunotherapy : CII, 2003, Volume: 52, Issue:7

    Topics: Adenocarcinoma; Animals; Antigens, Neoplasm; Antineoplastic Agents, Phytogenic; Biomarkers, Tumor; Cell Adhesion Molecules; Cell Survival; Chromium; Colonic Neoplasms; Epithelial Cell Adhesion Molecule; Female; G2 Phase; Humans; In Vitro Techniques; Lutetium; Male; Mice; Mice, Nude; Mitosis; Paclitaxel; Prostatic Neoplasms; Tumor Cells, Cultured; Vinblastine; Vinorelbine

2003
chemdatabank.com